Amprion Announces Presentation of Findings Related to Usage of the αSynuclein Seed Amplification Assay in Recent Parkinson's Study at 2023 AAN Annual Meeting

/PRNewswire/ -- Amprion is pleased to announce that it will attend the American Academy of Neurology (AAN) Annual Meeting in Boston April 22-27 to share...

Related Keywords

United States ,Texas ,American ,Michaelj Fox ,Amprion Syntap Biomarker ,Claudio Soto ,Russell Lebovitz ,Christina Renfroe ,Andrew Siderowf ,Prnewswire Amprion ,Ethan Metelenis ,Parkinson Progression Markers Initiative ,American Academy Of Neurology ,University Of Pennsylvania ,Michaelj Fox Foundation For Parkinson Research ,Movement Disorders Center ,Linkedin ,Michaelj Fox Foundation ,University Of Texas Health Sciences Center Houston ,Drug Administration ,Laboratory Developed Test ,Syn Seed Amplification Assay ,Progression Markers Initiative ,American Academy ,Annual Meeting ,Biomarker Test ,Exhibit Hall ,Emerging Neurologic Care Presentation ,Diagnostic Accuracy ,Disease Onset ,Lancet Neurology ,Lewy Body Dementia ,Lewy Body ,Breakthrough Device Designation ,Texas Health Sciences Center ,Amprion ,